BillionToOne (BLLN) Net Margin (2024 - 2026)

BillionToOne (BLLN) posted Net Margin of 16.58% for Q1 2026, up 529.2% sequentially from 2.64% in Q4 2025, and up 2334.0% YoY from 0.68% in Q1 2025.

BillionToOne (BLLN) Net Margin (2024 - 2026) Analysis & Trends

BillionToOne has reported Net Margin for 3 years, with the latest figure at 16.58% in Q1 2026.

Quarterly Net Margin rose 2334.0% year-over-year to 16.58% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5.19% (changed N/A YoY) and the FY2025 annual result came in at 0.96%, up 2820.0% from the prior year.
Net Margin improved to 16.58% in Q1 2026 per BLLN's latest filing, from 2.64% in the prior quarter.
Over five years, Net Margin peaked at 16.58% in Q1 2026 and troughed at 38.79% in Q3 2024.
A 3-year average of 8.33% and a median of 2.48% in 2025 frame the typical range for Net Margin.
The sharpest annual moves came in 2025 and 2026: Net Margin soared 4060 bps in 2025, then soared 2334 bps in 2026.
Over 3 years, Net Margin stood at 25.46% in 2024, then soared by 110 bps to 2.64% in 2025, then soared by 529 bps to 16.58% in 2026.
According to Business Quant data, Net Margin over the past three periods registered 16.58%, 2.64%, and 1.8% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Margin (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn	14.65%
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn	13.89%
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn	27.82%
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn	18.47%
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn	5.52%
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn	-12.22%
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn	17.86%
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn	22.67%
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn	10.65%
10	BillionToOne	6.88 Bn	6.34 Bn	79.10 Mn	16.58%

Download Data